Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02649946 · ClinicalTrials.gov registry record · NA
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 280
- Enrollment target
NCT02649946 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 280 participants.
The verdict
NCT02649946, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
Study Summary
The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
Interventions
- DEVICE Covera Vascular Covered Stent following PTA
- PROCEDURE Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2016-06 |
| Est. Completion | 2021-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02649946
The ClinicalTrials.gov registry entry for NCT02649946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Covera Vascular Covered Stent following PTA is the first listed.
NCT02649946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02649946 about?
NCT02649946 is a clinical study titled "Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft". The objective of this study is to assess the safety and effectiveness of the COVERA™ Vascular Covered Stent for the treatment of stenotic lesions in the upper extremity venous outflow of the Arteriovenous (AV) access circuit.
What is the current status of trial NCT02649946?
This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2016-06. Estimated completion is 2021-02.
What interventions are being tested in trial NCT02649946?
The interventions under investigation include: Covera Vascular Covered Stent following PTA (DEVICE), Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon (PROCEDURE).
Who is sponsoring clinical trial NCT02649946?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.